CVSI
CV Sciences, Inc.
Key Financials
Operating Income
$-470000
↑ 78.5%
Net Income
$-958000
↑ 60.0%
Revenue
$13.8M
↓ 12.2%
EPS (Diluted)
$-0.01
0.0%
Total Assets
$7.0M
↓ 12.2%
Cash & Equivalents
$611000.00
↓ 55.6%
Total Liabilities
$5.5M
↓ 10.4%
Gross Profit
$6.8M
↓ 5.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/9/2026 | View on SEC |
| 3 | 9/9/2026 | View on SEC |
| SCHEDULE 13G | 9/9/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 8-K | 6/4/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| DEF 14A | 4/15/2026 | View on SEC |
| 8-K | 4/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CVSI |
| Company Name | CV Sciences, Inc. |
| CIK | 1510964 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 866-290-2157 |